RALEIGH, N.C., Sept 4 (Bernama-GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (the “Company”) (NASDAQ: PRAH) today announced that KKR PRA Investors L.P. (the “Selling Stockholder”), intends to offer for sale in an underwritten secondary offering 6,666,684 shares of common stock of the Company pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission. The Selling Stockholder will receive all of the proceeds from this offering. No shares are being sold by the Company. The last reported sale price of the Company’s common stock on September 3, 2019 was $97.59 per share. The offering is expected to close on September 6, 2019, subject to customary closing conditions.
- September 4, 2019
0
272
Less than a minute
You can share this post!
administrator
Related Articles
GTLF Evolves With Private Sector Support
- November 22, 2024
H2O.ai Unveils Agentic AI that Converges Generative and…
- November 22, 2024
New Fast ID Solution Expands Shufti Into Both…
- November 22, 2024